{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:02:08Z","timestamp":1789678928015,"version":"4.0.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/jcp.0b013e3181faf670","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T09:06:35Z","timestamp":1288343195000},"page":"656-660","source":"Crossref","is-referenced-by-count":16,"title":["Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophrenia and Schizoaffective Disorder"],"prefix":"10.1097","volume":"30","author":[{"given":"Vicki P.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie G.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210128","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1176\/appi.ajp.162.10.1879","article-title":"Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.","volume":"162","author":"Breier","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R2-2-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.jcp.0000204137.82298.06","article-title":"A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.","volume":"26","author":"Kinon","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R3-2-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.","volume":"101","author":"Meyer","year":"2008","journal-title":"Schiz Res"},{"key":"R4-2-20210128","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1176\/ajp.161.10.1837","article-title":"Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.","volume":"161","author":"Simpson","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R5-2-20210128","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1176\/appi.ajp.162.8.1535","article-title":"Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.","volume":"162","author":"Simpson","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R6-2-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.","volume":"189","author":"Chrzanowski","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R7-2-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4088\/JCP.08m04421","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia.","volume":"70","author":"Kane","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"suppl 18","key":"R8-2-20210128","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.","volume":"65","author":"McQuade","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R9-2-20210128","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4088\/JCP.v68n1107","article-title":"Blood glucose and schizophrenia: a systematic review of prospective randomized clinical trials.","volume":"68","author":"Bushe","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R10-2-20210128","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2008.07.033","article-title":"A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia.","volume":"65","author":"Fleischhacker","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R11-2-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/JCP.0b013e31818aaf6c","article-title":"Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia.","volume":"28","author":"Kinon","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R12-2-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.jcp.0000219916.88810.1c","article-title":"Early predictors of substantial weight gain in bipolar patients treated with olanzapine.","volume":"26","author":"Lipkovich","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R14-2-20210128","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Association, American Psychiatric Association, American Association of Clinical Endocrinologists. Consensus development conference on antipsychotic drugs and obesity and diabetes.","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"R16-2-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oxfordjournals.schbul.a006926","article-title":"The Mount Sinai conference on the pharmacotherapy of schizophrenia.","volume":"28","author":"Marder","year":"2002","journal-title":"Schiz Bull"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201012000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:16:21Z","timestamp":1618035381000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201012000-00002"}},"subtitle":["Post Hoc Analyses of 3 Randomized, Controlled Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3181faf670","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}